medigraphic.com
Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán

2001, Número 4

<< Anterior Siguiente >>

Rev Biomed 2001; 12 (4)


Interleucinas e inmunidad innata.

Hernández-Urzúa MA, Alvarado-Navarro A

Idioma: Español
Referencias bibliográficas: 61
Paginas: 272-280
Archivo PDF: 89.84 Kb.


RESUMEN

La comunicación entre células inmunes e inflamatorias es mediada en gran parte por proteínas llamadas interleucinas, que promueven crecimiento, diferenciación y activación celular. Estas moléculas efectoras son producidas transitoriamente y controlan localmente la amplitud y duración de la respuesta. En ésta revisión son descritas tanto las interacciones entre citocinas y células, así como las principales características biológicas de las interleucinas involucradas en la respuesta inmune innata: IL-1, IL-6, quimiocinas, IL-10, IL-12, IL-15, IL-18, TNF-a e IFN-a, -b.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Fleisher TA, Bleesing JJ. Immune function. Pediatr Clin North Am 2000; 47:1197-209.

  2. Medzhitov R, Janeway CA Jr. Advances in Immunology: Innate Immunity. N Eng J Med 2000; 343: 338-44.

  3. Medzhitov R, Janeway C Jr. Innate immune recognition: mechanisms and pathways. Immunol Rev 2000; 173:89-97.

  4. Seder RA, Gazzinelli RT. Cytokines are critical in linking the innate and adaptive immune responses to bacterial, fungal, and parasitic infection. Adv Intern Med 1999; 44:353-88

  5. Rollinghoff M. Immunity, components of the immune system and immune response. Biologicals 1997; 25:165-8.

  6. Trinchieri G. Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-gamma). Curr Opin Immunol 1997; 9:17-23.

  7. Oberholzer A, Oberholzer C, Moldawer LL. Cytokine signaling--regulation of the immune response in normal and critically ill states. Crit Care Med 2000; 28 (Suppl):N3-12.

  8. Gery I, Waksman BH. Potentiation of the Tlymphocyte response to mitogens. II. The cellular source of potentiating mediator(s). J Exp Med 1972; 136:143-55.

  9. Dinarello CA. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol 1998;16:457-99.

  10. Weissenbach J, Chernajovsky Y, Zeevi M, Shulman L, Soreq H, Nir U, et al. Two interferon mRNAs in human fibroblats: In vitro translation and Escherichia coli cloning studies. Proc Natl Acad Sci USA 1980; 77:7152-6.

  11. Taga T, Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 1997;15:797-819.

  12. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, et al. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 1987; 84: 9233-7.

  13. Ward SG, Westwick J. Chemokines: understanding their role in T-lymphocyte biology. Biochem J 1998; 333 (Pt 3):457-70.

  14. Moser B, Loetscher M, Piali L, Loetscher P. Lymphocyte responses to chemokines. Int Rev Immunol 1998; 16:323-44.

  15. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989; 170: 827- 45.

  16. Gately MK, Renzetti LM, Magram J, Stern AS, Adorini L, Gubler U, et al. The interleukin-12/interleukin- 12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 1998;16:495-521.

  17. Trinchieri G. Immunobiology of interleukin-12. Immunol Res 1998; 17:269-78.

  18. Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc Natl Acad Sci USA 1957; 147:258.

  19. Sinigaglia F, D'Ambrosio D, Rogge L Type I interferons and the Th1/Th2 paradigm. Dev Comp Immunol 1999; 23:657-63.

  20. Carswell EA, Old LJ, Kaseel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necroses of tumors. Proc Natl Acad Sci USA 1975; 72: 3666-74.

  21. Brouckaert P, Libert C, Everaerdt B, Takahashi N, Cauwels A, Fiers W. Tumor necrosis factor, its receptors and the connection with interleukin 1 and interleukin 6. Immunobiology 1993; 187:317-29.

  22. Burton JD, Bamford RN, Peters C, Grant AJ, Kurys G, Goldman CK, et al. A lymphokine, provisionally designed interleukin T and produced by a human adult Tcell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 1994; 91:4935-9.

  23. Waldmann T, Tagaya Y, Bamford R. Interleukin-2, interleukin-15, and their receptors. Int Rev Immunol 1998; 16:205-26.

  24. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170:2081-95.

  25. Stordeur P, Goldman M. Interleukin-10 as a regulatory cytokine induced by cellular stress: molecular aspects. Int Rev Immunol 1998; 16:501-22.

  26. Nakamura K, Okamura H, Wada M, Nagata K, Tamura T. Endotoxin-induced serum factor that stimulates gamma interferon production. Infect Immun 1989; 57:590-9.

  27. Lebel-Binay S, Berger A, Zinzindohoue F, Cugnenc P, Thiounn N, Fridman WH, et al. Interleukin-18: biological properties and clinical implications. Eur Cytokine Netw 2000 Mar;11:15-26.

  28. Dinarello CA. IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 1999; 103:11-24.

  29. Risso A. Leukocyte antimicrobial peptides: multifunctional effector molecules of innate immunity. J Leukoc Biol 2000; 68:785-92.

  30. Ochsenbein AF, Zinkernagel RM. Natural antibodies and complement link innate and acquired immunity. Immunol Today 2000; 21:624-30.

  31. Nonaka M. Evolution of the complement system. Curr Opin Immunol 2001; 13:69-73.

  32. Zhang Y, Suankratay C, Zhang XH, Lint TF, Gewurz H. Lysis via the lectin pathway of complement activation: minireview and lectin pathway enhancement of endotoxininitiated hemolysis. Immunopharmacology 1999; 42:81-90.

  33. Ulevitch RJ, Tobias PS. Receptor-dependent mechanism of cell stimulation by bacterial endotoxin. Annu Rev Immunol 1995; 13:437-57.

  34. Linehan SA, Martinez-Pomares L, Gordon S. Macrophage lectins in host defence. Microbes Infect 2000; 2:279-88.

  35. Kopp EB, Medzhitov R. The Toll-receptor family and control of innate immunity. Curr Opin Immunol 1999; 11:13-8.

  36. Stein-Streilein J, Sonoda KH, Faunce D, Zhang- Hoover J. Regulation of adaptive immune responses by innate cells expressing NK markers and antigentransporting macrophages. J Leukoc Biol 2000; 67:488-94.

  37. Murphy JE, Robert C, Kupper TS. Interleukin-1 and cutaneous inflammation: a crucial link between innate and acquired immunity. J Invest Dermatol 2000; 114:602-8.

  38. Beutler BA. The role of tumor necrosis factor in health and disease. J Rheumatol 1999;26 (Suppl 57):16-21.

  39. Mantovani A. The chemokine system: redundancy for robust outputs. Immunol Today 1999; 20:254-7.

  40. Lukacs NW, Kunkel SL. Chemokines and their role in disease. Int J Clin Lab Res 1998; 28:91-5.

  41. Bogdan C, Rollinghoff M, Diefenbach A. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr Opin Immunol 2000; 12:64-76.

  42. Boyaka PN, Lillard JW Jr, McGhee J. Interleukin 12 and innate molecules for enhanced mucosal immunity. Immunol Res 1999; 20:207-17.

  43. Akira S. The role of IL-18 in innate immunity. Curr Opin Immunol 2000; 12:59-63.

  44. Trinchieri G. Proinflammatory and immunoregulatory functions of interleukin-12. Int Rev Immunol 1998; 16: 365-96.

  45. Spellberg B, Edwards JE. Type 1/Type 2 immunity in infectious diseases. Clin Infect Dis 2001; 32:76-102.

  46. Yoshikai Y, Nishimura H. The role of interleukin 15 in mounting an immune response against microbial infections. Microbes Infect 2000; 2:381-9.

  47. Carson W, Caligiuri MA. Interleukin-15 as a potential regulator of the innate immune response. Braz J Med Biol Res 1998; 31:1-9.

  48. Vales-Gomez M, Reyburn H, Strominger J. Interaction between the human NK receptors and their ligands. Crit Rev Immunol 2000; 20:223-44.

  49. Meeusen EN, Balic A. Do eosinophils have a role in the killing of helminth parasites? Parasitol Today 2000; 16: 95-101.

  50. Bogdan C. The function of type I interferons in antimicrobial immunity. Curr Opin Immunol 2000; 12:419-24.

  51. Suffredini AF, Fantuzzi G, Badolato R, Oppenheim JJ, O'Grady NP. New insights into the biology of the acute phase response. J Clin Immunol 1999; 19:203-14.

  52. Gadient RA, Otten UH. Interleukin-6 (IL-6)-a molecule with both beneficial and destructive potentials. Prog Neurobiol 1997; 52:379-90.

  53. DiPiro JT. Cytokine networks with infection: mycobacterial infections, leishmaniasis, human immunodeficiency virus infection, and sepsis. Pharmacotherapy 1997; 17:205-23.

  54. Holgate ST. The role of mast cells and basophils in inflammation. Clin Exp Allergy 2000;30 (Suppl 1):28-32.

  55. Smith EM, Cadet P, Stefano GB, Opp MR, Hughes TK Jr. IL-10 as a mediator in the HPA axis and brain. J Neuroimmunol 1999; 100:140-8.

  56. Opal SM, De Palo VA. Anti-inflammatory cytokines. Chest 2000; 117:1162-72.

  57. Ma X, Montaner LJ. Proinflammatory response and IL-12 expression in HIV-1 infection. J Leukoc Biol 2000; 68:383-90.

  58. McNicholl JM, Downer MV, Udhayakumar V, Alper CA, Swerdlow DL. Host-pathogen interactions in emerging and re-emerging infectious diseases: a genomic perspective of tuberculosis, malaria, human immunodeficiency virus infection, hepatitis B, and cholera. Annu Rev Public Health 2000; 21:15-46.

  59. Gough PJ; Gordon S. The role of scavenger receptors in the innate immune system. Microbes Infect 2000; 2: 305-11.

  60. Medzhitov R, Janeway CA Jr. Innate immunity: impact on the adaptive immune response. Curr Opin Immunol 1997; 9:4-9.

  61. Banyer JL, Hamilton NH, Ramshaw IA, Ramsay AJ. Cytokines in innate and adaptive immunity. Rev Immunogenet 2000; 2:359-73.




2020     |     www.medigraphic.com